About Universitaetsklinikum des Saarlandes; medizinische Klinik und Poliklinik; Innere Medizin I
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Universitaetsklinikum des Saarlandes; medizinische Klinik und Poliklinik; Innere Medizin I
During the past decade, Universitaetsklinikum des Saarlandes; medizinische Klinik und Poliklinik; Innere Medizin I conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on
average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Universitaetsklinikum des Saarlandes; medizinische Klinik und Poliklinik; Innere Medizin I"
#1 collaborator was "Genentech, Inc." with 1 trials as a collaborator, "German Low Grade Lymphoma Study Group" with 1 trials as a collaborator, "Institute of Cancer Research, United Kingdom" with 1 trials as a collaborator and "Janssen Research & Development, LLC" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Universitaetsklinikum des Saarlandes; medizinische Klinik und Poliklinik; Innere Medizin I
According to Clinical.Site data, the most researched conditions in "Universitaetsklinikum des Saarlandes; medizinische Klinik und Poliklinik; Innere Medizin I" are
"B-cell Lymphoma" (1 trials), "Chronic Myeloid Leukemia" (1 trials), "Hemoglobinuria, Paroxysmal" (1 trials), "Mantle-Cell Lymphoma" (1 trials) and "Non-Hodgkin's Lymphoma" (1 trials). Many other conditions were trialed in "Universitaetsklinikum des Saarlandes; medizinische Klinik und Poliklinik; Innere Medizin I" in a lesser frequency.
Clinical Trials Intervention Types at Universitaetsklinikum des Saarlandes; medizinische Klinik und Poliklinik; Innere Medizin I
Most popular intervention types in "Universitaetsklinikum des Saarlandes; medizinische Klinik und Poliklinik; Innere Medizin I" are "Drug" (8 trials). Other intervention types were less common.
The name of intervention was led by "Rituximab" (3 trials), "eculizumab" (2 trials), "Bendamustine" (1 trials), "Bevacizumab" (1 trials) and "CHOP" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Universitaetsklinikum des Saarlandes; medizinische Klinik und Poliklinik; Innere Medizin I
The vast majority of trials in "Universitaetsklinikum des Saarlandes; medizinische Klinik und Poliklinik; Innere Medizin I" are
8 trials for "All" genders.
Clinical Trials Status at Universitaetsklinikum des Saarlandes; medizinische Klinik und Poliklinik; Innere Medizin I
Currently, there are NaN active trials in "Universitaetsklinikum des Saarlandes; medizinische Klinik und Poliklinik; Innere Medizin I".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Universitaetsklinikum des Saarlandes; medizinische Klinik und Poliklinik; Innere Medizin I,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Universitaetsklinikum des Saarlandes; medizinische Klinik und Poliklinik; Innere Medizin I, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".